Abstract Claims Description Full Text

Abstract

Described are solid dose nanoparticulate naproxen formulations having high rates of dissolution. The solid dose nanoparticulate naproxen formulations can comprise an alkali compound, which functions to increase the dissolution rate of the naproxen following administration. Alternatively, the solid dose nanoparticulate naproxen formulation can comprise an alkali compound and an acidic compound, which can react together to form carbon dioxide. The formed carbon dioxide can also aid in increasing the dissolution rate of the naproxen following administration. Also described are solid dose nanoparticulate naproxen formulations having a decreased concentration of a binder/disintegrant agent. Such compositions also provide an increased rate of dissolution of naproxen following administration.

Other References

• Boylan et al., American Association Production Staff, Library of Congress, (1986), 2 pages
• Budavari et al., The Merck Index, National Institutes of Health, (1990), p. 1014
• Gennaro, "Oral Solid Dosage Forms," Remington's Pharmaceutical Sciences., Chapter 89 1633-41 (1990)
• Kristensen et al., "Relief of Pain and Trismus in Patients Treated with Naproxen or Acetylsalicylic Acid After Tonsillectomy", J. Laryngol Otol., 102 (1):39-42 (1988)
• Hespe et al., "Bioavailability of New Formulations of Amoxicillin in Relation to its Absorption Kinetics", Arzneimittelforschung, 37 (3): 372-5 (1987)
• Spitz, "Determination of Water in Aluminum Chlorohydrate and Effervescent Tablets by Karl Fischer Analysis", J. Pharm Sci., 68(1): 122-3 (1979)
• Ross-Lee et al., Plasma Levels of Aspirin Following Effervescent and Enteric Coated Tablets, and Their Effect on Platelet Function, Eur J. Clin Pharmacol, 23 (6): 545-51 (1982)
• Nishimura et al., "Dosage Form Design for Improvement of Bioavailability of Levodopa VI: Formulation of Effervescent Enteric-Coated tablets", J. Pharm Sci., 73(7): 942-6 (1984)
• Sendall et al., "A Study of Powder Adhesion to Metal Surfaces During Compression of Effervescent Pharmaceutical Tablets", J. Pharm. Pharmacol., 38(7): 489-93 (1986